CONTACT INFORMATIONBIOGRAPHYCREDENTIALSPATENTSPUBLICATIONSMajed A. Refaai, M.D.Contact InformationPhone NumbersOffice: (585) 276-3927Fax: (585) 273-3003A member of the University of Rochester Medical Faculty GroupgroupAn Accountable Health PartnerassignmentAccepting New PatientsLocationsUniversity of Rochester Medical CenterSchool of Medicine and Dentistry601 Elmwood Ave, Box 608Rochester, NY 14642Faculty AppointmentsProfessor - Department of Pathology and Laboratory Medicine (SMD) Patient Care SettingPathologyBiographyDr. Refaai's clinical service is in Transfusion Medicine with subspecialty involvement in laboratory coagulation/thrombosis testing.ResearchDr. Refaai's recent studies have included: The in-vitro effect of ABO anti-bodies on platelet function; The correlation between cancer and tissue factor (TF) plasma concentrations and its role in developing DVT; The relationship between the circulating TF and the cancer tissue concentrations of TF in different types of mouse models; Beriplex phase IIIb drug study for bleeding patients with Warfarin overdose; Beriplex phase IIIb drug study for surgical patients who require a quick reversal of Warfarin; The effect of ABO non-identical blood products transfusion on platelet function (in-vivo); Platelet transfusion in patients with positive heparin-induced thrombocytopenia; Comparison of tissue factor pathway inhibitor (TFPI) concentration and activity in mononuclear cells from normal individuals versus patients with Paroxysmal Nocturnal Hemoglobinuria; Comparison of TFPI concentrations in normal mouse plasma and endothelial cells versus a diabetic mouse model; Analysis of fatty acid ethyl ester (FAEE) concentrations in binge drinking, chronic alcoholics, and postmortem biopsies.CredentialsSpecialtiesClinical Pathology/Laboratory Medicine - American Board of PathologyEducation1993MD | Aleppo UniversityPost-doctoral Training & Residency07/01/2006 - 06/30/2007Fellowship in Tranfusion Medicine at University of Texas Southwestern06/30/2003 - 06/30/2006Residency in Pathology at Barnes-Jewish Hospitals04/01/1997 - 05/31/2003Research at Massachusetts General HospitalVIEW ALL expand_morePatentsPatent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients Patent #: 3265116 Issue Date: Jun 02, 2021 Country: Europe Invented By: Majed A RefaaiPatent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients Patent #: FR3265116 Issue Date: Jun 02, 2021 Country: France Invented By: Majed A RefaaiPatent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients Patent #: DE3265116 Issue Date: Jun 02, 2021 Country: Germany Invented By: Majed A RefaaiPatent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients Patent #: GB3265116 Issue Date: Jun 02, 2021 Country: United Kingdom Invented By: Majed A RefaaiPatent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients Patent #: ZL 201680012653.9 Issue Date: Mar 19, 2021 Country: China, People's Republic of Invented By: Majed A RefaaiPatent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients Patent #: 10,722,608 Issue Date: Jul 28, 2020 Country: United States Invented By: Majed A RefaaiVIEW ALL expand_morePublicationsJournal Articles12/27/2021McRae HL, Milito C, Klapheke CA, Refaai MA. "Evaluation of solvent/detergent-treated plasma safety and efficacy in orthotopic liver transplant and thrombotic thrombocytopenic purpura patients: A single center experience." Transfusion.. 2021 Dec 27; Epub 2021 Dec 27. 12/7/2021McRae HL, Millar MW, Slavin SA, Blumberg N, Rahman A, Refaai MA. "Essential Role of Rho-Associated Kinase in ABO Immune Complex-Mediated Endothelial Barrier Disruption." Biomedicines.. 2021 Dec 7; 9(12)Epub 2021 Dec 07. 10/2021Refaai MA, Jacobson AK, Rosenfeld JC, Orr RR. "Performance of the microINR Point-of-Care System Used by Self-Testing Patients: A Multicenter Clinical Trial." . 2021 Oct 0; 5(4):e577-e584. Epub 2021 Dec 30. VIEW ALL PUBLICATIONSClose WindowSchedule an appointment with Majed A. Refaai, M.D.Please answer the following questions to help us find the right appointment for you.Important: If you believe that you have a medical or psychiatric emergency, please call 911 or go to the nearest hospital. This website is not intended for emergency care.Have you seen this provider in the last 2 years?YesNoExisting Patient Schedule or request a follow up appointment online through MyChart. If you do not have a MyChart account, please close this window and call the appointment phone number. Majed A. Refaai, M.D. is currently scheduling for the following appointment type(s): Our policy does not permit patients to establish care with multiple providers within the same practice or specialty without prior approval. If you choose a new provider in the same office, we will cancel the appointment. Please contact the office directly with questions on this policy.